A critical breakthrough in cancer study is emerging with the use of VHH fragments to re-engage dysfunctional p53. This crucial malignant suppressor protein is frequently lost in many types of malignancies, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research